Optimize Your Health - Available Everywhere in the US

  188-8981-6784    HIPAA Compliant  ·  Licensed U.S. Providers

Thymosin Beta-4 (TB-4)

Thymosin Beta-4 (TB-4) — Tissue Repair & Recovery Research Peptide. Licensed provider-Supervised.

Thymosin Beta-4 is a naturally occurring 43-amino-acid peptide found in virtually every tissue and cell type in the human body. It has been studied extensively for its role in wound healing, tissue regeneration, and inflammatory response regulation. At OptiMale USA, TB-4 is available as part of a physician-supervised recovery protocol following comprehensive clinical evaluation.

WHAT IS IT?

Understanding Thymosin Beta-4

Thymosin Beta-4 (TB-4) was originally isolated from thymosin fraction 5, a thymic extract investigated for immunological properties. It is now understood to be present throughout the body, with particularly high concentrations in platelets, wound fluid, and blood cells. Its primary research interest centres on its role as a regulator of actin — the protein responsible for cell structure, movement, and repair processes. By sequestering G-actin monomers, TB-4 helps modulate the cytoskeletal changes involved in cell migration, which is central to the tissue repair process.

Research has studied TB-4 across contexts including musculoskeletal injury, cardiac tissue recovery, wound healing, and neurological protection. Preclinical and early clinical investigations have explored its application for tendon, ligament, and muscle injuries, as well as its potential to support angiogenesis — the formation of new blood vessels — in damaged tissue. At OptiMale USA, TB-4 protocols are individualised by a licensed physician following assessment of your injury history, activity level, and health profile.

Thymosin Alpha 1
Quick Facts

Injection

Timeline: Immune marker improvements within 2-4 weeks; full therapeutic effects at 6-12 weeks
Lab required: Yes
Ongoing maintenance: Yes; continuous or pulsed protocols
Pricing:  Contact for Pricing

Related Treatments

Benefits

Tissue repair and remodelling research

TB-4 has been studied for its role in promoting the migration of repair cells to injury sites. Research in preclinical models has examined its influence on muscle, tendon, and ligament repair, with particular interest in how actin regulation affects the speed and quality of tissue remodelling following injury.

Angiogenesis and vascular support research

Investigations into TB-4 have examined its effects on angiogenesis — the process by which new capillaries form in damaged tissue. This vascular support is considered relevant to recovery because adequate blood supply to injured areas is associated with the delivery of nutrients and removal of inflammatory byproducts.

Inflammatory response modulation research

TB-4 has been studied in the context of inflammatory signalling, with research examining whether it influences the regulation of inflammatory cytokines at injury sites. Clinical interest has focused on whether this modulation translates to more controlled healing responses in musculoskeletal injuries.

Cardiac and neurological recovery research

Beyond musculoskeletal applications, TB-4 has been investigated in preclinical cardiac injury models and neurological contexts. Research has explored its potential relevance in cardiac tissue repair following ischaemic events and in neuroprotection — areas that continue to be studied in ongoing research programs.

Who Is This For?

Am I a Good Candidate?

Ideal For

  • Men recovering from musculoskeletal injuries — tendon, ligament, or muscle damage — who are working within a physician-supervised recovery protocol
  • Men engaged in high-intensity training or athletic programs who are assessed as appropriate candidates following clinical evaluation
  • Men seeking a research-supported adjunct to conventional physiotherapy or rehabilitation under physician guidance
  • Men who have completed a consultation including bloodwork and health history review at OptiMale USA

Not Recommended If

  • Men with active malignancy or a history of hormone-sensitive cancers — TB-4’s cellular effects have not been fully characterised in oncology contexts
  • Men with acute infections or uncontrolled inflammatory conditions
  • Men who have not undergone individual clinical assessment by an OptiMale USA provider
  • Men under 18 or those with conditions contraindicating injectable peptide therapy
Safety

Potential Side Effects

Thymosin alpha 1 has an extensively characterised safety profile from decades of clinical use and multiple randomised controlled trials. It is generally very well tolerated. All OptiMale USA patients are monitored throughout.

Common Questions

Frequently Asked Questions

Get started

Ready to learn whether Thymosin Beta-4 is right for you?

Your free consultation is the first step. A licensed OptiMale USA provider will review your bloodwork, health history, and goals before making any recommendations.

thymosin-alpha-1

These statements have not been evaluated by the Food and Drug Administration. The information on this website is provided for educational and informational purposes only and does not constitute medical advice, a diagnosis, a treatment recommendation, or an offer to prescribe, supply, compound, administer, or dispense any product.

Compounded medications. Compounded medications, including compounded semaglutide and compounded tirzepatide, are not FDA-approved and are not generic equivalents of brand-name products such as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. The FDA does not review compounded drugs for safety, effectiveness, or quality prior to dispensing. Compounded medications are prepared by state-licensed 503A compounding pharmacies or FDA-registered 503B outsourcing facilities pursuant to a valid prescription from a licensed provider following individual patient evaluation. Availability of compounded medications varies by state and is subject to applicable state and federal law.

Research compounds. Certain compounds referenced on this website are research compounds that are not approved by the FDA for human use and have not been evaluated by the FDA for safety, efficacy, or quality. Information about these compounds is provided solely for educational and informational purposes and reflects publicly available scientific literature. OptiMale USA and its affiliated providers do not prescribe, supply, recommend, compound, administer, or dispense research compounds, and nothing on this website should be construed as an offer to do so. Patient consent forms purporting to waive provider duty of care with respect to research compounds are not recognized as a defense to professional liability and are not used by OptiMale USA.

Clinical services. All prescription products and services offered through OptiMale USA are prescribed exclusively by board-certified, licensed U.S. providers following individual clinical evaluation, comprehensive bloodwork where indicated, and a detailed health assessment. Available services and products vary by state based on provider licensure and applicable law. No provider-patient relationship is established by use of this website; a provider-patient relationship is formed only upon completion of a clinical evaluation with a licensed OptiMale USA provider.

Individual results vary. Always consult a qualified healthcare provider before beginning any new health protocol.

  • Home
  • Products
  • Solutions
  • How it Works
  • Peptide Library